Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786409 · ClinicalTrials.gov registry record · NA
Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT00786409 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 27 participants.
The verdict
NCT00786409, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the immunogenicity and safety of the HPV vaccine Gardasil in young women.
Interventions
- BIOLOGICAL Gardasil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00786409
The ClinicalTrials.gov registry entry for NCT00786409 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gardasil is the first listed.
NCT00786409 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00786409 about?
NCT00786409 is a clinical study titled "Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women". The purpose of this study is to evaluate the immunogenicity and safety of the HPV vaccine Gardasil in young women.
What is the current status of trial NCT00786409?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2008-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00786409?
The interventions under investigation include: Gardasil (BIOLOGICAL).
Who is sponsoring clinical trial NCT00786409?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.